Latest Insider Transactions at Option Care Health, Inc. (OPCH)
This section provides a real-time view of insider transactions for Option Care Health, Inc. (OPCH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Option Care Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Option Care Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 26
2024
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,829
-2.2%
|
$401,041
$29.45 P/Share
|
|
Oct 26
2024
|
John Charles Rademacher Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,216
+4.74%
|
-
|
|
Oct 21
2024
|
Nicole Maggio Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
342
-2.27%
|
$10,260
$30.51 P/Share
|
|
Oct 21
2024
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
911
-2.1%
|
$27,330
$30.51 P/Share
|
|
Oct 21
2024
|
Christopher L. Grashoff Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
911
-3.47%
|
$27,330
$30.51 P/Share
|
|
Oct 21
2024
|
Luke Whitworth Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,785
-3.21%
|
$113,550
$30.51 P/Share
|
|
Oct 21
2024
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,570
-2.86%
|
$227,100
$30.51 P/Share
|
|
Oct 21
2024
|
Michael H. Shapiro Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,088
+6.07%
|
-
|
|
Sep 03
2024
|
R Carter Pate Director |
SELL
Open market or private sale
|
Direct |
1,465
-3.9%
|
$46,880
$32.37 P/Share
|
|
Sep 03
2024
|
R Carter Pate Director |
SELL
Bona fide gift
|
Direct |
67,342
-64.18%
|
-
|
|
Aug 22
2024
|
Michael H. Shapiro Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,217
-8.58%
|
$696,510
$30.95 P/Share
|
|
Aug 22
2024
|
Michael H. Shapiro Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,217
+7.9%
|
$417,906
$18.97 P/Share
|
|
Aug 22
2024
|
Timothy P Sullivan Director |
SELL
Open market or private sale
|
Direct |
47,249
-69.42%
|
$1,417,470
$30.91 P/Share
|
|
Aug 21
2024
|
Elizabeth Quadros Betten Director |
SELL
Open market or private sale
|
Direct |
47,531
-69.02%
|
$1,473,461
$31.09 P/Share
|
|
Aug 15
2024
|
Michael Bavaro Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
5,765
-11.72%
|
$178,715
$31.42 P/Share
|
|
Aug 15
2024
|
Michael Bavaro Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,765
+3.9%
|
$132,595
$23.93 P/Share
|
|
May 19
2024
|
Collin Smyser GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-0.57%
|
$6,902
$29.78 P/Share
|
|
May 19
2024
|
Collin Smyser GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
812
+1.89%
|
-
|
|
May 19
2024
|
Christopher L. Grashoff Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,522
-5.48%
|
$44,138
$29.78 P/Share
|
|
May 15
2024
|
Eric Brandt Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+50.0%
|
-
|
|
May 15
2024
|
Natasha Deckmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,985
+26.62%
|
-
|
|
May 15
2024
|
Elizabeth D Bierbower Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+22.04%
|
-
|
|
May 15
2024
|
Elizabeth Quadros Betten Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+7.18%
|
-
|
|
May 15
2024
|
John Arlotta Director |
BUY
Grant, award, or other acquisition
|
Indirect |
9,150
+11.41%
|
-
|
|
May 15
2024
|
R Carter Pate Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+4.83%
|
-
|
|
May 15
2024
|
Harry M Jansen Kraemer Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,806
+4.65%
|
-
|
|
May 15
2024
|
David W Golding Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,219
+5.49%
|
-
|
|
May 15
2024
|
Barbara W. Bodem Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+43.01%
|
-
|
|
May 15
2024
|
Norman L. Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+43.01%
|
-
|
|
May 15
2024
|
Timothy P Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+7.26%
|
-
|
|
May 09
2024
|
R Carter Pate Director |
SELL
Bona fide gift
|
Direct |
6,504
-6.13%
|
-
|
|
Apr 22
2024
|
Femi Adewunmi Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,867
+50.0%
|
-
|
|
Apr 01
2024
|
Norman L. Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,731
+50.0%
|
-
|
|
Apr 01
2024
|
Barbara W. Bodem Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,731
+50.0%
|
-
|
|
Mar 09
2024
|
Luke Whitworth Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,373
-1.15%
|
$43,936
$32.34 P/Share
|
|
Feb 28
2024
|
Michael Bavaro Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,984
-4.37%
|
$61,504
$31.73 P/Share
|
|
Feb 26
2024
|
Harry M Jansen Kraemer Jr Director |
BUY
Open market or private purchase
|
Direct |
35,000
+11.49%
|
$1,085,000
$31.55 P/Share
|
|
Feb 23
2024
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99,252
-14.27%
|
$3,176,064
$32.24 P/Share
|
|
Feb 23
2024
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,109
-9.22%
|
$803,488
$32.24 P/Share
|
|
Feb 23
2024
|
Christopher L. Grashoff Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217
-0.77%
|
$6,944
$32.24 P/Share
|
|
Feb 23
2024
|
Luke Whitworth Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,363
-3.29%
|
$267,616
$32.24 P/Share
|
|
Feb 23
2024
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217
-0.48%
|
$6,944
$32.24 P/Share
|
|
Feb 22
2024
|
Luke Whitworth Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
978
-0.76%
|
$31,296
$32.55 P/Share
|
|
Feb 22
2024
|
Christopher L. Grashoff Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
375
-1.32%
|
$12,000
$32.55 P/Share
|
|
Feb 22
2024
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,295
-0.76%
|
$169,440
$32.55 P/Share
|
|
Feb 22
2024
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,270
-0.46%
|
$40,640
$32.55 P/Share
|
|
Feb 22
2024
|
Collin Smyser GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
619
-1.48%
|
$19,808
$32.55 P/Share
|
|
Feb 22
2024
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
450
-0.98%
|
$14,400
$32.55 P/Share
|
|
Feb 21
2024
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,930
-0.7%
|
$162,690
$33.36 P/Share
|
|
Feb 21
2024
|
John Charles Rademacher Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,087
+1.55%
|
-
|